Literature DB >> 34080331

Ductal Stenting and Judicious Avoidance of Septostomy Rapidly Retrain a Regressed Left Ventricle in D Transposition: A Case Report.

Avinash Anantharaj1, Bhagwati Prasad Pant2, Nagendra Singh Thalor2, Harapriya Balasubramanian3, Robert Coelho3.   

Abstract

Entities:  

Year:  2021        PMID: 34080331      PMCID: PMC8592682          DOI: 10.4250/jcvi.2020.0209

Source DB:  PubMed          Journal:  J Cardiovasc Imaging


× No keyword cloud information.
A 39-day-old infant (weight, 3.2 kg; length, 52 mm) with dextro-transposition of the great arteries (d-TGA) (saturating 72%) and an intact inter-ventricular septum (IVS) and unobstructed left ventricular (LV) outflow presented to our clinic. The inter-atrial septal (IAS) length was 21 mm. An atrial septal defect (ASD) (3.6 mm) (Figure 1A) and a closing patent ductus arteriosus (PDA) (Figures 1C and 2A) allowed inter-circulatory mixing. The LV was squashed by the right ventricle (RV) (Figure 2C), regressed, and banana-shaped (end-diastolic left ventricular posterior wall thickness [LVPWd], 3 mm; end-diastolic left ventricular internal dimension [LVIDd], 13.4 mm; left ventricular indexed mass [LVmi], 37 g/m2). Since the interatrial mean gradient, which measured 1 mm Hg on catheterization and 2 mm Hg on echocardiography (Figure 1B),1) revealed effective inter-atrial mixing, we avoided balloon atrial septostomy. Furthermore so since increasing the ASD/IAS ratio (0.18) might hinder successful LV retraining.2)3)
Figure 1

(A) Native atrial septal defect (ASD) measured in the sub-xiphoid coronal view. (B) Continuous wave Doppler across the inter-atrial septum (IAS) showing an inter-atrial mean gradient of 2 mm Hg. (C) Suprasternal long axis view of the aortic arch (Ao arch) at baseline in color compare mode zoomed in to focus on the PDA, showing the large aortic end (Ao end) and the extremely narrow pulmonary end (PA end) (<0.5 mm), suggestive of imminent closure. A measurement obtained during echocardiography and intra-procedural sizing (after balloon dilatation of the narrowed pulmonary end) using a coronary balloon with 2 marker bands agreed on a ductal length of 12 mm. (D) Four days after ductal stenting, a suprasternal long axis view of the aortic arch showed a well-flowing ductal stent.

Asc Ao: ascending aorta, Desc Ao: descending aorta, IVS: inter ventricular septum, LA: left atrium, LV: left ventricle, RA: right atrium, RV: right ventricle.

Figure 2

(A) Aortogram reveals an extremely narrowed and closing pulmonary end of the PDA. (B) Post-stenting aortogram shows a well-expanded stent. (C) End systolic frame from a baseline echocardiogram at presentation shows a squashed banana-shaped left ventricle on day 39 of life. (D) Apical 4 chamber view frozen in an end systolic frame showing IVS in midline. The LV was no longer banana-shaped. (E) At presentation, the baseline echocardiographic images in the parasternal short axis view at the papillary muscle level frozen in an end systolic frame shows an ellipsoid LV (classification from Leong et al.2)) with the IVS pushed toward the LV. (F) Four days after stenting, the parasternal short axis view at the papillary muscle level frozen in an end systolic frame shows a well-expanded LV in a satisfactory configuration (classification from Leong et al.2)) with the IVS pushed toward the RV.

Ao: aorta, IVS: inter-ventricular septum, LV: left ventricular, PA: pulmonary artery, PDA: patent ductus arteriosus, RV: right ventricle.

The LV/RV pressure ratio of 0.654) mandated LV retraining. Since prolonged post-operative support was impractical during coronavirus disease 2019 (COVID-19) pandemic, we performed ductal stenting (4 × 16 mm, everolimus-eluting; Promus Element Plus; Boston Scientific, Natick, MA, USA)5) instead of surgical retraining. There was no aortic arch/branch pulmonary artery (PA) encroachment (Figures 1D and 2B, Movie 1). The patient's oxygen saturation improved to 90%. The shunt induced congestive failure, that was compounded by the restrictive ASD required intensive therapy with diuretics. Echocardiography on post-procedure day four revealed that the IVS had shifted toward the midline (Figure 2D and Movie 2) and the LV that was ellipsoid-shaped (Figure 2E), demonstrated transformation to a “satisfactory configuration” (LVPWd, 3.8 mm; LVIDD, 24.3 mm; LVmi, 90 g/m2) (Figure 2F and Movie 2).2) Successful arterial switch and stent explantation (Figure 3) were done 17 days later. The patient's postoperative course was uneventful, with normal RV function, normal PA pressures, and minimal neo-aortic regurgitation.
Figure 3

Explanted ductal stent.

  5 in total

1.  Ductal stenting retrains the left ventricle in transposition of great arteries with intact ventricular septum.

Authors:  Kothandam Sivakumar; Edwin Francis; Prasad Krishnan; Jagdish Shahani
Journal:  J Thorac Cardiovasc Surg       Date:  2006-11       Impact factor: 5.209

2.  The infant with transposition of the great arteries. II. Results of balloon atrial septostomy.

Authors:  W H Neches; C E Mullins; D G McNamara
Journal:  Am Heart J       Date:  1972-11       Impact factor: 4.749

3.  Left ventricular regression after balloon atrial septostomy in d-transposition of the great arteries.

Authors:  Arun Gopalakrishnan; Bijulal Sasidharan; Kavassery Mahadevan Krishnamoorthy; Sivasankaran Sivasubramonian; Baiju S Dharan; Thomas Mathew; Thomas Titus; Ajitkumar Valaparambil; Jaganmohan Tharakan
Journal:  Eur J Cardiothorac Surg       Date:  2016-06-14       Impact factor: 4.191

4.  Ductal Stenting to Retrain the Involuted Left Ventricle in d-Transposition of the Great Arteries.

Authors:  Ming Chern Leong; Abdalrahman Ali Ahmed Alhassan; Sivakumar Sivalingam; Mazeni Alwi
Journal:  Ann Thorac Surg       Date:  2019-04-15       Impact factor: 4.330

5.  Late presenters with dextro-transposition of great arteries and intact ventricular septum: to train or not to train the left ventricle for arterial switch operation?

Authors:  Noor Mohamed Parker; Muhammed Zuhdi; Amjad Kouatli; Ghassan Baslaim
Journal:  Congenit Heart Dis       Date:  2009 Nov-Dec       Impact factor: 2.007

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.